US3563235A - Intrauterine contraceptive method - Google Patents
Intrauterine contraceptive method Download PDFInfo
- Publication number
- US3563235A US3563235A US760688A US3563235DA US3563235A US 3563235 A US3563235 A US 3563235A US 760688 A US760688 A US 760688A US 3563235D A US3563235D A US 3563235DA US 3563235 A US3563235 A US 3563235A
- Authority
- US
- United States
- Prior art keywords
- copper
- zinc
- group
- metal
- intrauterine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 24
- 230000002254 contraceptive effect Effects 0.000 title claims description 18
- 239000003433 contraceptive agent Substances 0.000 title claims description 16
- 229910052751 metal Inorganic materials 0.000 claims abstract description 37
- 239000002184 metal Substances 0.000 claims abstract description 36
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 34
- 229910052802 copper Inorganic materials 0.000 claims abstract description 27
- 239000010949 copper Substances 0.000 claims abstract description 27
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 15
- 239000011701 zinc Substances 0.000 claims abstract description 15
- 150000002739 metals Chemical class 0.000 claims abstract description 12
- 229910052709 silver Inorganic materials 0.000 claims description 5
- 239000004332 silver Substances 0.000 claims description 5
- 229910045601 alloy Inorganic materials 0.000 claims description 4
- 239000000956 alloy Substances 0.000 claims description 4
- 238000003780 insertion Methods 0.000 claims description 2
- 230000037431 insertion Effects 0.000 claims description 2
- 230000002035 prolonged effect Effects 0.000 claims description 2
- 230000000717 retained effect Effects 0.000 claims description 2
- 238000002513 implantation Methods 0.000 abstract description 19
- 239000011888 foil Substances 0.000 abstract description 3
- 238000012986 modification Methods 0.000 abstract description 3
- 230000004048 modification Effects 0.000 abstract description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 11
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 7
- 230000003187 abdominal effect Effects 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 4
- 238000002695 general anesthesia Methods 0.000 description 4
- 230000013011 mating Effects 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 230000035935 pregnancy Effects 0.000 description 4
- 210000000754 myometrium Anatomy 0.000 description 3
- 238000010171 animal model Methods 0.000 description 2
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002357 endometrial effect Effects 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 229910001316 Ag alloy Inorganic materials 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- -1 Group B Chemical class 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 238000005275 alloying Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- YCKOAAUKSGOOJH-UHFFFAOYSA-N copper silver Chemical compound [Cu].[Ag].[Ag] YCKOAAUKSGOOJH-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012260 resinous material Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
Definitions
- a method of contraception is disclosed characterized by providing for the presence of elemental copper or zinc in the uterine cavity. This invention is preferably practiced by wrapping a small amount of wire or foil or by placing a sleeve around a conventional intrauterine device prior to implantation. In a modification of this method, two different metals are employed to provide improved effectiveness.
- intrauterine contraceptive devices In view of these disadvantages of conventional control pills, use of intrauterine contraceptive devices has achieved considerable popularity. Such devices may be inserted inexpensively in patients in large scale programs, and moreover, do not require reliance upon a patientss willingness or ability to follow a particular regimen of treatment. Despite these advantages of the intrauterine contraceptive devices which are already available and being manufactured commercially, it has been found that they are not as effective as the socalled conventional birth control pills, provided the latter are used within the prescribed regimen. Accordingly, considerable effort has been directed toward improving the efficacy of intrauterine contraceptive devices.
- the elemental metal may be inserted or implanted in the uterine cavity by any convenient method. Normally, only a relatively small amount is required, for example, a small piece of copper or zinc wire in the order of l to 2 centimeters in length and a fraction of a millimeter in diameter is effective. The effectiveness of a given quantity of metal appears to be related to the exposed surface area. In general it is believed that an exposed metallic surface of at least about 20 square millimeters is sufficient. Larger amounts may be used so long as the size of the insert is not unacceptable.
- copper-silver alloys containing up to 90 percent silver copper-tin containing alloys such as certain admiralty metals and bronzes (which may also contain other alloying elements such as zinc, phosphorus, aluminum, manganese, etc.
- a modification of the present invention which has been found to improve effectiveness of the copper or zinc is to provide for the presence of a second dissimilar metal.
- the second metallic element appears to have a synergistic effect on the copper or zinc since bimetallic couples are even more effective as contraceptives.
- Any combination of a variety of pharmaceutically acceptable metals or alloys thereof may be used; for example, silver, stainless steel, gold, platinum, tin, brass, bronze, and the like. it will be obvious, moreover, that the combination of copper and zinc themselves can be used as a twometal system for improving the efficacy of the present invention.
- EXAMPLE 1 Comparative tests were performed on a group of patients to ascertain the relative effectiveness under clinical conditions of the presence of'a small amount of copper in the form of wire carried on an intrauterine device.
- a T-shaped plastic intrauterine device was placed in 250 members of the group as a control. In the control group no exogenous copper, zinc or other free elemental metal was present on the intrauterine device. In the balance of the group the same intrauterine 1 device was used modified by winding; a piece of copper wire, 3
- the elemental metal in implanted wit within the uterine cavity by means of a carrier, for which purpose any of the conventional intrauterine contraceptive devices are eminently suitable.
- the metal may be deposited onto the carrier in the following manners: (a) it could be in the form of wire which would be wound around a portion of the carrier; (b) the metal could be in the form of foil and could be wrapped around the carrier; (c) the metal could be in the form of tubing and could he slipped onto a portion of the carrier as a sleeve and swaged in place by pressure; (d) the metal could be applied to the carrier by means of a plating process; (e) metal filings, powder, etc. may be intimately blended with the resinous material from which the intrauterine device is made.
- EXAMPLE 3 The contraceptive properties of metallic zinc were determined in experimental animals in the following manner:
- EXAMPLE 4 In order to illustrate the contraceptive properties of copper are related to the amount of surface are of the copper which is exposed within the uterine cavity, the following experiment was performed.
- EXAMPLE 5 The effectiveness of a twometal system was studied by implantation of copper and silver couples in the rabbit uterus. The study was performed as follows:
- the silver wire used in Group C did not produce an effect on implantation rates.
- the amount of copper was increased in Group D, no implantations were observed in the right uterine horn where the wires were placed. Implantations were normal in the contralateral horn. This example clearly illustrates that when two metals are mechanically combined and inserted in the uterine cavity, the contraceptive properties are greater than then when one or the other metal is used alone.
- a method of contraception which comprises placing a contraceptively effective amount of an elemental metal selected from the group consisting of copper and zinc in the uterine cavity.
- An intrauterine contraceptive device adaptable to insertion in the uterine cavity and capable of being retained therein for prolonged periods of time, said device including a contraceptively effective amount of an elemental metal selected from the group consisting of copper and zinc.
Landscapes
- Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Abstract
A method of contraception is disclosed characterized by providing for the presence of elemental copper or zinc in the uterine cavity. This invention is preferably practiced by wrapping a small amount of wire or foil or by placing a sleeve around a conventional intrauterine device prior to implantation. In a modification of this method, two different metals are employed to provide improved effectiveness.
Description
United States Patent inventor Jaime A. Zipper Santiago, Chile Sept. 18, 1968 Feb. 16, 1971 By mesne assignments, to G. D. Searle & Co. Chicago, Ill.
Appl. No. Filed Patented Assignee INTRAUTERINE CONTRACEPTIVE METHOD 8 Claims, No Drawings References Cited UNITED STATES PATENTS Primary Examiner-Adele M. Eager Attorney-Curtis, Morris & Safford ABSTRACT: A method of contraception is disclosed characterized by providing for the presence of elemental copper or zinc in the uterine cavity. This invention is preferably practiced by wrapping a small amount of wire or foil or by placing a sleeve around a conventional intrauterine device prior to implantation. In a modification of this method, two different metals are employed to provide improved effectiveness.
INTRAUTERINE CONTRACEPTIVE METHOD This invention relates to an improved contraceptive method.
During recent past years, due to world population pressures, a vast amount of research has been undertaken directed to developing improved contraceptive methods. One such method which has gained wide favor because of its high effectiveness is to employ certain hormones known to modify the body endocrinology and suppress ovulation. These hormones, popularly administered as birth control pills, if used regularly, prove to be highly effective and reliable for controlling conception. Nevertheless, they are not without difficulties when used in large scale birth control programs in developed and in developing countries, not only because they are relatively expensive, but also because considerable reliance has to be placed upon the patient to take the pills in accordance-with the prescribed regimen.
In view of these disadvantages of conventional control pills, use of intrauterine contraceptive devices has achieved considerable popularity. Such devices may be inserted inexpensively in patients in large scale programs, and moreover, do not require reliance upon a patientss willingness or ability to follow a particular regimen of treatment. Despite these advantages of the intrauterine contraceptive devices which are already available and being manufactured commercially, it has been been found that they are not as effective as the socalled conventional birth control pills, provided the latter are used within the prescribed regimen. Accordingly, considerable effort has been directed toward improving the efficacy of intrauterine contraceptive devices.
In accordance with the present invention, it has been found that the presence of elemental copper of zinc in the uterine cavity is highly effective to prevent conception.
The elemental metal may be inserted or implanted in the uterine cavity by any convenient method. Normally, only a relatively small amount is required, for example, a small piece of copper or zinc wire in the order of l to 2 centimeters in length and a fraction of a millimeter in diameter is effective. The effectiveness of a given quantity of metal appears to be related to the exposed surface area. In general it is believed that an exposed metallic surface of at least about 20 square millimeters is sufficient. Larger amounts may be used so long as the size of the insert is not unacceptable.
' to 65 percent copper; copper-silver alloys containing up to 90 percent silver; and copper-tin containing alloys such as certain admiralty metals and bronzes (which may also contain other alloying elements such as zinc, phosphorus, aluminum, manganese, etc.
A modification of the present invention which has been found to improve effectiveness of the copper or zinc is to provide for the presence of a second dissimilar metal. The second metallic element appears to have a synergistic effect on the copper or zinc since bimetallic couples are even more effective as contraceptives. Any combination of a variety of pharmaceutically acceptable metals or alloys thereof may be used; for example, silver, stainless steel, gold, platinum, tin, brass, bronze, and the like. it will be obvious, moreover, that the combination of copper and zinc themselves can be used as a twometal system for improving the efficacy of the present invention.
The present invention may be further understood by reference to the following examples:
EXAMPLE 1 Comparative tests were performed on a group of patients to ascertain the relative effectiveness under clinical conditions of the presence of'a small amount of copper in the form of wire carried on an intrauterine device. A T-shaped plastic intrauterine device was placed in 250 members of the group as a control. In the control group no exogenous copper, zinc or other free elemental metal was present on the intrauterine device. In the balance of the group the same intrauterine 1 device was used modified by winding; a piece of copper wire, 3
centimeters in length and millimeters in diameter, around V RESULTS OF IMPLANTATION OF INTRAUTERINE DEVICES PER 100 USERS Small quantities of foreign material in the uterine cavity,
however, would not ordinarily have the desired longevity of action because they would be quickly expelled or sloughed off either through muscular uterine contractions or during the period of regular menstrual flow. Preferably, therefore, the elemental metal in implanted wit within the uterine cavity by means of a carrier, for which purpose any of the conventional intrauterine contraceptive devices are eminently suitable. A
wide variety of such devices are known, i.e., single or multiple loops, spirals, crosses, and various sinuous shapes. The metal may be deposited onto the carrier in the following manners: (a) it could be in the form of wire which would be wound around a portion of the carrier; (b) the metal could be in the form of foil and could be wrapped around the carrier; (c) the metal could be in the form of tubing and could he slipped onto a portion of the carrier as a sleeve and swaged in place by pressure; (d) the metal could be applied to the carrier by means of a plating process; (e) metal filings, powder, etc. may be intimately blended with the resinous material from which the intrauterine device is made.
The contraceptive properties of metallic copper were determined in experimental animals in the following manner:
served as the site of the intrauterine device.
Under general anesthesia an abdominal incision was made and a l.5 cm. length of wire consisting of four strands of wire each of which was 0.15 mm. in diameter was inserted in the lower portion of the cavity of the right uterine horn close to the cervical os. The wire was fastened in place by a silk suture through the myometrium in order to avoid expulsion. The left horn remained intact.
After a week of rest the rabbits were mated. Ten days after mating, the occurence of pregnancy was determined by obf serving the implantation sites through an abdominal incision.
There were no implantations in the right uterine horn which contained the copper wire. There were, however, an average Adult virgirial rabbits were used. lln each instance, thele ft uterine horn served as the control and the right uterine horn of 4.1 implantations per rabbit in the left uterine horn which had remained intact. This example illustrates clearly and definitely that copper serves as a potent antifertility agent when it lies in the endometrial cavity.
EXAMPLE 3 The contraceptive properties of metallic zinc were determined in experimental animals in the following manner:
Adult virginal rabbits were used. In each instance, the left uterine horn served as the control and the right uterine horn served as the site of the intrauterine device.
Under general anesthesia an abdominal incision was made and a 1.5 cm. length of zinc wire of 0.5 mm. diameter was inserted in the lower portion of the cavity of the right uterine horn close to the cervical s. The wire was fastened in place by a silk suture through the myometrium in order to avoid expulsion. The left horn remained intact.
After a week of rest the rabbits were mated. Ten days after mating, the occurence of pregnancy was determined by observing the implantation sites through an abdominal incision. There were no implantations in the right uterine hornwhich contained the zinc wire. There were, however, an average of 3.5 implantations per rabbit in the left uterine horn which had remained intact. This example illustrates clearly and definitely that zinc serves as a potent antifertility agent when it lies in the endometrial cavity.
EXAMPLE 4 In order to illustrate the contraceptive properties of copper are related to the amount of surface are of the copper which is exposed within the uterine cavity, the following experiment was performed.
Adult virginal rabbits were divided into two groups. Under general anesthesia and by the same surgical technique described in Examples 2 and 3, a single 1.5 cm. length of copper wire 0.20 mm. in diameter was affixed within the right uterine horn of the animals in Group A, The same procedure was followed in Group B except that four 1.5 cm. segments of copper wire 0.20 mm. in diameter were wound together and were affixed within the right uterine horn. The left uterine horns of all animals in both Groups A and B were kept intact and served as controls.
After a week of rest the rabbits were mated. Ten days after mating, the occurence of pregnancy was determined by observing the implantation sites through an abdominal incision. There were no implantations in the right horns of the animals in Group B. There was no evidence of reduced implantation in the right or in the left horn of the animals in Group A. This example clearly illustrates that the contraceptive properties of copper are determined to some degree by the surface area of copper which is exposed within the uterine cavity.
EXAMPLE 5 The effectiveness of a twometal system was studied by implantation of copper and silver couples in the rabbit uterus. The study was performed as follows:
Adult virginal rabbits were divided in four groups. Under general anesthesia the following foreign bodies were inserted in the lower portion of the cavity of the right uterine horn close to the cervical 05. These were fastened in place by a silk suture through the myometrium in order to avoid expulsion. In all four groups the left uterine horn was kept intact and thus served as the control. The foreign body affixed within the right uterine horn in the four groups was as follows:
Group A-a single copper wire 0,20 mm. diameter and 1.5
cm. long; Group B-a single copper wire 0.20 mm. diameter and 1.5 cm. long wound around a silver wire 0.35 mm. diameter and 1.5 cm. long;
Group C-a silver wire 0.35 mm. diameter and 1.5 cm. long; Group D-four copper wires 0.20 mm. diameter and 1.5 cm.
long.
After a week of rest the rabbits were mated. Ten days after mating, the occurence of pregnancy was determined by observing the implantation sites through an abdominal incision. In group A it was found that the presence of a single copper wire 0.20 mm. in diameter and 1.5 cm. long did not produce a marked effect on implantation rates in either the right uterine horn where the wire was implanted or in the contralateral horn. On the other hand, the presence of the two metals, i.e., Group B, with the same quantity of copper as in Group A, showed a remarkable decrease in the number of implantations in the right uterine horn where the two wires were placed. lmplantations were normal in the contralateral horn. The silver wire used in Group C did not produce an effect on implantation rates. When the amount of copper was increased in Group D, no implantations were observed in the right uterine horn where the wires were placed. Implantations were normal in the contralateral horn. This example clearly illustrates that when two metals are mechanically combined and inserted in the uterine cavity, the contraceptive properties are greater than then when one or the other metal is used alone.
I claim:
1. A method of contraception which comprises placing a contraceptively effective amount of an elemental metal selected from the group consisting of copper and zinc in the uterine cavity.
2. A method as in claim 1 wherein a said elemental metal is attached to an intrauterine device effective to retain said metal in the uterine cavity over a prolonged period of time.
3. A method as in claim 1 wherein said metal in is in the form of a pharmaceutically acceptable alloy.
4. A method as in claim 1 wherein two dissimilar pharmaceutically acceptable metals are placed in the uterine cavity in contact with each other, at least one of said metals being selected from the group consisting of copper and zinc.
5. A method as in claim 4 wherein said dissimilar metals are silver and copper.
6. A method as in claim 1 wherein said elemental metal has an exposed surface area of at least about 20 square millimeters.
7. An intrauterine contraceptive device adaptable to insertion in the uterine cavity and capable of being retained therein for prolonged periods of time, said device including a contraceptively effective amount of an elemental metal selected from the group consisting of copper and zinc.
8. An intrauterine contraceptive device as in claim 7 wherein said elemental metal has an exposed surface area of at least about 20 square millimeters.
Claims (7)
- 2. A method as in claim 1 wherein a said elemental metal is attached to an intrauterine device effective to retain said metal in the uterine cavity over a prolonged period of time.
- 3. A method as in claim 1 wherein said metal in is in the form of a pharmaceutically acceptable alloy.
- 4. A method as in claim 1 wherein two dissimilar pharmaceutically acceptable metals are placed in the uterine cavity in contact with each other, at least one of said metals being selected from the group consisting of copper and zinc.
- 5. A method as in claim 4 wherein said dissimilar metals are silver and copper.
- 6. A method as in claim 1 wherein said elemental metal has an exposed surface area of at least about 20 square millimeters.
- 7. An intrauterine contraceptive device adaptable to insertion in the uterine cavity and capable of being retained therein for prolonged periods of time, said device including a contraceptively effective amount of an elemental metal selected from the group consisting of copper and zinc.
- 8. An intrauterine contraceptive device as in claim 7 wherein said elemental metal has an exposed surface area of at least about 20 square millimeters.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76068868A | 1968-09-18 | 1968-09-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3563235A true US3563235A (en) | 1971-02-16 |
Family
ID=25059875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US760688A Expired - Lifetime US3563235A (en) | 1968-09-18 | 1968-09-18 | Intrauterine contraceptive method |
Country Status (2)
Country | Link |
---|---|
US (1) | US3563235A (en) |
CA (1) | CA941254A (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3620212A (en) * | 1970-06-15 | 1971-11-16 | Robert D Fannon Jr | Intrauterine contraceptive device |
US3683905A (en) * | 1970-03-16 | 1972-08-15 | Marc E Chaft | Intra-uterine contraceptive devices |
US3834378A (en) * | 1970-11-12 | 1974-09-10 | Robins Co Inc A H | Intrauterine device |
US3877461A (en) * | 1971-06-21 | 1975-04-15 | Investors In Ventures Inc | Device for controlling body fluids |
DE2361206A1 (en) * | 1973-12-06 | 1975-06-19 | Schering Ag | Intra-uterine device contg. active medicaments - and mfd. from plastic materials |
US3973560A (en) * | 1973-07-27 | 1976-08-10 | A. H. Robins Company, Incorporated | Intrauterine device of C or omega form |
US4018220A (en) * | 1974-07-19 | 1977-04-19 | Lionel C. R. Emmett | Method of insertion for intrauterine device of C or omega form with tubular inserter |
US4111196A (en) * | 1973-07-27 | 1978-09-05 | Lionel C. R. Emmett | Intrauterine contraceptive device of c or omega form with tubular inserter and method of placement |
FR2479685A1 (en) * | 1980-04-02 | 1981-10-09 | Outokumpu Oy | COPPER WIRE FOR BIRTH CONTROL DEVICE, INTRA-UTERIN AND METHOD OF MANUFACTURE |
US4353363A (en) * | 1978-11-23 | 1982-10-12 | Angel Sopena Quesada | Intrauterine spermicide |
EP0152193A1 (en) * | 1984-01-23 | 1985-08-21 | Ortho Pharmaceutical (Canada) Ltd | Streamlined t-shaped intrauterine device and method of preventing conception |
WO1985004798A1 (en) * | 1984-04-19 | 1985-11-07 | University Of Queensland | Contraceptive methods and delivery systems therefore |
WO1990002478A1 (en) * | 1988-09-14 | 1990-03-22 | Francesco Pianetti | Bimetallic spiral intrauterine device |
US5224493A (en) * | 1991-01-30 | 1993-07-06 | Cadco Corporation | Contraceptive intracervical device and novel nonsystemic agents for the prevention of conception and disease |
WO1997016142A2 (en) * | 1995-11-01 | 1997-05-09 | Bernd Hamann | Intrauterine contracteptive pessary |
US20040127918A1 (en) * | 1995-06-07 | 2004-07-01 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and methods |
US20040211429A1 (en) * | 1995-06-07 | 2004-10-28 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
EP1902693A1 (en) * | 2006-09-20 | 2008-03-26 | Melinda-Kinga Karpati | Intrauterine contraceptive device |
US20090277463A1 (en) * | 1999-08-23 | 2009-11-12 | Conceptus, Inc., A California Corporation | Deployment Actuation System for Intrafallopian Contraception |
WO2011030345A1 (en) * | 2009-09-09 | 2011-03-17 | Vhb Pharmaceuticals Pvt. Ltd. | A threadless intrauterine contraceptive implant and a method for manufacture |
ITBO20110229A1 (en) * | 2011-04-28 | 2012-10-29 | Alberto Mazzanti | INTRAUTERINO DISCUSSION (IUD) |
US20130019374A1 (en) * | 2011-01-04 | 2013-01-24 | Schwartz Alan N | Gel-based seals and fixation devices and associated systems and methods |
US9907691B2 (en) | 2013-03-13 | 2018-03-06 | Hologic, Inc. | Intrauterine contraceptive devices |
US10342476B2 (en) | 2012-05-17 | 2019-07-09 | Alan N. Schwartz | Localization of the parathyroid |
US11045246B1 (en) | 2011-01-04 | 2021-06-29 | Alan N. Schwartz | Apparatus for effecting feedback of vaginal cavity physiology |
US11337858B2 (en) | 2011-11-21 | 2022-05-24 | Alan N. Schwartz | Ostomy pouching system |
US11406438B2 (en) | 2011-09-23 | 2022-08-09 | Alan N. Schwartz | Instrument for therapeutically cytotoxically ablating parathyroidal tissue within a parathyroid gland |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US454573A (en) * | 1891-06-23 | Electrical pessary | ||
US662716A (en) * | 1900-07-31 | 1900-11-27 | John G L Gaedeke | Intra-uterine battery. |
US709675A (en) * | 1901-10-04 | 1902-09-23 | Albert Heimann | Pessary. |
US982996A (en) * | 1910-04-19 | 1911-01-31 | J B Eldridge | Wire spring-stem pessary. |
US1896071A (en) * | 1931-04-24 | 1933-02-07 | George A Clark | Pessary |
-
1968
- 1968-09-18 US US760688A patent/US3563235A/en not_active Expired - Lifetime
-
1969
- 1969-09-16 CA CA062,129A patent/CA941254A/en not_active Expired
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US454573A (en) * | 1891-06-23 | Electrical pessary | ||
US662716A (en) * | 1900-07-31 | 1900-11-27 | John G L Gaedeke | Intra-uterine battery. |
US709675A (en) * | 1901-10-04 | 1902-09-23 | Albert Heimann | Pessary. |
US982996A (en) * | 1910-04-19 | 1911-01-31 | J B Eldridge | Wire spring-stem pessary. |
US1896071A (en) * | 1931-04-24 | 1933-02-07 | George A Clark | Pessary |
Cited By (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3683905A (en) * | 1970-03-16 | 1972-08-15 | Marc E Chaft | Intra-uterine contraceptive devices |
US3620212A (en) * | 1970-06-15 | 1971-11-16 | Robert D Fannon Jr | Intrauterine contraceptive device |
US3834378A (en) * | 1970-11-12 | 1974-09-10 | Robins Co Inc A H | Intrauterine device |
US3877461A (en) * | 1971-06-21 | 1975-04-15 | Investors In Ventures Inc | Device for controlling body fluids |
US3973560A (en) * | 1973-07-27 | 1976-08-10 | A. H. Robins Company, Incorporated | Intrauterine device of C or omega form |
US4111196A (en) * | 1973-07-27 | 1978-09-05 | Lionel C. R. Emmett | Intrauterine contraceptive device of c or omega form with tubular inserter and method of placement |
DE2361206A1 (en) * | 1973-12-06 | 1975-06-19 | Schering Ag | Intra-uterine device contg. active medicaments - and mfd. from plastic materials |
US4018220A (en) * | 1974-07-19 | 1977-04-19 | Lionel C. R. Emmett | Method of insertion for intrauterine device of C or omega form with tubular inserter |
US4353363A (en) * | 1978-11-23 | 1982-10-12 | Angel Sopena Quesada | Intrauterine spermicide |
FR2479685A1 (en) * | 1980-04-02 | 1981-10-09 | Outokumpu Oy | COPPER WIRE FOR BIRTH CONTROL DEVICE, INTRA-UTERIN AND METHOD OF MANUFACTURE |
EP0152193A1 (en) * | 1984-01-23 | 1985-08-21 | Ortho Pharmaceutical (Canada) Ltd | Streamlined t-shaped intrauterine device and method of preventing conception |
JPS60215355A (en) * | 1984-01-23 | 1985-10-28 | オ−ソ・フア−マシユ−チカル・(カナダ)・リミテツド | Streamline t-shaped intrauterine apparatus |
JPH0675584B2 (en) | 1984-01-23 | 1994-09-28 | オーソ・フアーマシユーチカル・(カナダ)・リミテツド | T-shaped intrauterine device |
WO1985004798A1 (en) * | 1984-04-19 | 1985-11-07 | University Of Queensland | Contraceptive methods and delivery systems therefore |
US4959216A (en) * | 1984-04-19 | 1990-09-25 | University Of Queensland | Contraceptive methods and delivery systems thereof |
WO1990002478A1 (en) * | 1988-09-14 | 1990-03-22 | Francesco Pianetti | Bimetallic spiral intrauterine device |
US5433217A (en) * | 1988-09-14 | 1995-07-18 | Pianetti; Francesco | Bimetallic spiral intrauterine device |
US5224493A (en) * | 1991-01-30 | 1993-07-06 | Cadco Corporation | Contraceptive intracervical device and novel nonsystemic agents for the prevention of conception and disease |
US7921848B2 (en) | 1995-06-07 | 2011-04-12 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and methods |
US8733361B2 (en) | 1995-06-07 | 2014-05-27 | Bayer Essure Inc. | Occlusion devices and methods |
US20040127918A1 (en) * | 1995-06-07 | 2004-07-01 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and methods |
US20040211429A1 (en) * | 1995-06-07 | 2004-10-28 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
US20070044808A1 (en) * | 1995-06-07 | 2007-03-01 | Conceptus, Inc., A California Corporation | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
US20070144528A1 (en) * | 1995-06-07 | 2007-06-28 | Julian Nikolchev | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
US8356599B2 (en) | 1995-06-07 | 2013-01-22 | Conceptus, Inc. | Occlusion devices and methods |
US8327852B2 (en) | 1995-06-07 | 2012-12-11 | Conceptus, Inc. | Occlusion devices and methods |
US8171936B2 (en) | 1995-06-07 | 2012-05-08 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and methods |
US8066007B2 (en) | 1995-06-07 | 2011-11-29 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
US20110030696A1 (en) * | 1995-06-07 | 2011-02-10 | Nikolchev Julian N | Contraceptive transcervical fallopian tube occlusion devices and methods |
WO1997016142A2 (en) * | 1995-11-01 | 1997-05-09 | Bernd Hamann | Intrauterine contracteptive pessary |
WO1997016142A3 (en) * | 1995-11-01 | 1997-07-31 | Bernd Hamann | Intrauterine contracteptive pessary |
US8733360B2 (en) | 1997-09-24 | 2014-05-27 | Bayer Essure Inc. | Occlusion devices and methods |
US8613282B2 (en) | 1997-09-24 | 2013-12-24 | Conceptus, Inc. | Occlusion devices and methods |
US8381733B2 (en) | 1999-08-23 | 2013-02-26 | Conceptus, Inc. | Deployment actuation system |
US9597224B2 (en) | 1999-08-23 | 2017-03-21 | Bayer Healthcare Llc | Deployment actuation system |
US7934504B2 (en) | 1999-08-23 | 2011-05-03 | Conceptus, Inc. | Deployment actuation system for intrafallopian contraception |
US8079364B2 (en) | 1999-08-23 | 2011-12-20 | Conceptus, Inc. | Deployment actuation system for intrafallopian contraception |
US8695604B2 (en) | 1999-08-23 | 2014-04-15 | Bayer Essure Inc. | Deployment actuation system |
US20090277463A1 (en) * | 1999-08-23 | 2009-11-12 | Conceptus, Inc., A California Corporation | Deployment Actuation System for Intrafallopian Contraception |
US8584679B2 (en) | 1999-08-23 | 2013-11-19 | Conceptus, Inc. | Deployment actuation system |
US8118028B2 (en) * | 2006-09-20 | 2012-02-21 | Melinda-Kinga Karpati | Intrauterine contraceptive device |
EP1902693A1 (en) * | 2006-09-20 | 2008-03-26 | Melinda-Kinga Karpati | Intrauterine contraceptive device |
WO2008034619A1 (en) * | 2006-09-20 | 2008-03-27 | Melinda-Kinga Karpati | Intrauterine contraceptive device |
AU2007299190B2 (en) * | 2006-09-20 | 2012-07-12 | Melinda-Kinga Karpati | Intrauterine contraceptive device |
JP2010504296A (en) * | 2006-09-20 | 2010-02-12 | メリンダ−キンガ・カルパティ | Intrauterine device |
US20090311306A1 (en) * | 2006-09-20 | 2009-12-17 | Melinda-Kinga Karpati | Intrauterine contraceptive device |
CN101534757B (en) * | 2006-09-20 | 2011-06-15 | 梅琳达·金嘉·卡尔帕蒂 | Intrauterine device |
NO340562B1 (en) * | 2006-09-20 | 2017-05-15 | Karpati Melinda Kinga | Intrauterine contraceptive device |
WO2011030345A1 (en) * | 2009-09-09 | 2011-03-17 | Vhb Pharmaceuticals Pvt. Ltd. | A threadless intrauterine contraceptive implant and a method for manufacture |
US11045246B1 (en) | 2011-01-04 | 2021-06-29 | Alan N. Schwartz | Apparatus for effecting feedback of vaginal cavity physiology |
US20130019374A1 (en) * | 2011-01-04 | 2013-01-24 | Schwartz Alan N | Gel-based seals and fixation devices and associated systems and methods |
US11806275B2 (en) | 2011-01-04 | 2023-11-07 | Alan N. Schwartz | Penile condom catheter for facilitating urine collection and egress of urinary fluids away from the body torso |
ITBO20110229A1 (en) * | 2011-04-28 | 2012-10-29 | Alberto Mazzanti | INTRAUTERINO DISCUSSION (IUD) |
WO2012147064A1 (en) * | 2011-04-28 | 2012-11-01 | Mazzanti Alberto | Intra -uterine device |
US11406438B2 (en) | 2011-09-23 | 2022-08-09 | Alan N. Schwartz | Instrument for therapeutically cytotoxically ablating parathyroidal tissue within a parathyroid gland |
US11337858B2 (en) | 2011-11-21 | 2022-05-24 | Alan N. Schwartz | Ostomy pouching system |
US11974951B2 (en) | 2011-11-21 | 2024-05-07 | Alan N. Schwartz | Pair of eye goggles |
US10342476B2 (en) | 2012-05-17 | 2019-07-09 | Alan N. Schwartz | Localization of the parathyroid |
US12127846B2 (en) | 2012-05-17 | 2024-10-29 | Alan N. Schwartz | Localization of the parathyroid |
US9907691B2 (en) | 2013-03-13 | 2018-03-06 | Hologic, Inc. | Intrauterine contraceptive devices |
Also Published As
Publication number | Publication date |
---|---|
CA941254A (en) | 1974-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3563235A (en) | Intrauterine contraceptive method | |
US3533406A (en) | Intrauterine contraceptive device | |
US4034749A (en) | Intrauterine contraceptive device | |
EP2079413B1 (en) | Intrauterine contraceptive device | |
WO1985004798A1 (en) | Contraceptive methods and delivery systems therefore | |
FI58053C (en) | FOER MAENNISKOR AVSETT CONTRACEPTIONSMEDEL | |
US3993058A (en) | Intrauterine device with seeker for finding the cervical os and housing member for fitting device in an inserter | |
Margulies | History of intrauterine devices | |
US3834378A (en) | Intrauterine device | |
USRE28399E (en) | Intrauterine contraceptive method | |
Zipper et al. | Four years experience with the Cu7 200 device-endouterine copper in fertility control | |
CA2218666A1 (en) | Method of contraception | |
Prager | Effect of various types of intrauterine foreign bodies on the incorporation of 35S into mucoprotein and of thymidine 2-14C into DNA of rat's endometrium | |
Goldstuck | Delayed postcoital IUD insertion | |
GB2121289A (en) | Intrauterine contraceptive device and method of its production | |
Shaila et al. | A comparative randomized double-blind study of the copper-T200 and copper-7 intrauterine contraceptive devices with modified insertion techniques | |
Kamal et al. | Pregnancies in the Presence of Copper Intra‐uterine Devices: Hysterosalpingographic studies | |
Zipper et al. | An overview of IUD research and implications for the future | |
Laufe et al. | Nonsurgical female sterilization | |
Mccarthy et al. | Intrauterine devices | |
AU588807B2 (en) | Cu edta/ascorbic acid contraceptive | |
Sadovsky et al. | Report on the use of the New Anderson-Ansell “Latex Leaf” IUD containing copper and zinc | |
Laufe et al. | Modification of the CuT 220C for immediate postpartum use | |
Chowdhury et al. | Comparative study of Lippes Loop and CuT inserted in immediate post-abortal period | |
Nnatu | Comprehensive overview of intrauterine contraceptive device (IUCD) |